Dexamethasone Injection

Product Description

DESCRIPTION:OZURDEX is an intravitreal implant containing 0.7 mg dexamethasone in the NOVADUR solid polymer drug delivery system. OZURDEX is preloaded into a single-use, specially designed DDS applicator to facilitate injection of the rod-shaped implant directly into the vitreous. The NOVADUR system contains poly PLGA intravitreal polymer matrix. OZURDEX is preservative-free.INDICATIONS AND USAGEOZURDEX contains a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion BRVO or central retinal vein occlusion.DOSAGE AND ADMINISTRATION:

For ophthalmic intravitreal injection only.

The intravitreal injection procedure should be carried out under controlled aseptic conditions. Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis.

Versatile Application and Usage

Dexamethasone Injection is utilized in the management of diverse medical conditions, such as severe allergies, inflammation, autoimmune disorders, and also as adjunct therapy in specific cancer treatments. Its adaptable formulation allows for controlled administration, tailored to each patient's requirements by healthcare providers.


Strict Storage and Handling Standards

To safeguard the integrity of Dexamethasone Injection, it must be kept in a cool, dry environment, away from direct sunlight and heat. Adhering to proper storage guidelines helps retain its efficacy and makes it ready for safe use whenever required in a medical setting.